Skip to content

Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration

Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04523194
Enrollment
1000
Registered
2020-08-21
Start date
2020-11-09
Completion date
2027-12-31
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis

Brief summary

The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. The main goal of this collaboration is to create a resource to promote further understanding of the pathobiology of atherosclerosis through image analysis.

Detailed description

The purpose of this collaboration is to establish a multi-modality image database including coronary angiograms, optical coherence tomography (OCT), computed tomography angiograms (CTA) and cardiac magnetic resonance imaging (CMR) for future studies. About one thousand patients who underwent coronary angiography with OCT and had a CTA prior to catheterization at Tsuchiura Kyodo General Hospital (TKGH) in Japan, will be included. A subset of these patients also had CMR. The main goal of this collaboration is to create a resource to promote further understanding of the pathobiology of atherosclerosis through image analysis.

Interventions

OTHEROptical Coherence Tomography (OCT) and Computed Tomography Angiography (CTA)

Subjects underwent CTA, then OCT during cardiac catheterization as part of their standard clinical care.

Sponsors

Tsuchiura Kyodo General Hospital
CollaboratorOTHER
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Had CTA prior to cardiac catheterization and then OCT during catheterization

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Major Adverse Cardiac Events (MACE)1 YearMACE

Countries

Japan, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026